| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8633785 | Neuropeptides | 2017 | 32 Pages |
Abstract
Combination therapy with ChABC and hADSCs exhibits more significant functional recovery than single therapy using either. This result may be applicable in selection of the best therapeutic strategy for SCI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Arash Sarveazad, Asrin Babahajian, Mehrdad Bakhtiari, Mansoureh Soleimani, Babak Behnam, Abazar Yari, Abolfazl Akbari, Mahmoud Yousefifard, Atousa Janzadeh, Naser Amini, Shahram Agah, Ali Fallah, Mohammad Taghi Joghataei,